Jubilant Life Sciences, an integrated pharma and life sciences company, announced today that its indirect wholly-owned subsidiary, Jubilant Generics, has successfully completed its previously announced tender offer for of the outstanding shares of Cadista Holding common stock not owned by Jubilant Generics or its affiliates.

Based upon information provided by the depositary for the tender offer, as of the expiration of the tender offer, a total of 17,018,378 shares were validly tendered and not withdrawn in the tender offer, representing approximately 82% of Cadista Holdings' currently outstanding shares not already owned by Jubilant Generics and its affiliates. Jubilant Generics has accepted for payment all validly tendered shares.

Shares of the company gained Rs 0.2, or 0.16%, to trade at Rs 124.20. The total volume of shares traded was 19,825 at the BSE (12.37 p.m., Tuesday).